Vivid Financial Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,834	Closed	-$297K	–	148
2021 Q2	$297K	Buy	1,834 +72	+4%	+$11.7K	0.12%	123
2021 Q1	$215K	Buy	1,762 +363	+26%	+$44.3K	0.1%	139
2020 Q4	$214K	Buy	+1,399	New	+$214K	0.1%	124